NCT06552234
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06552234
Title Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC (REPOROS)
Acronym REPOROS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CH Aix-en-Provence RECRUITING Aix-en-Provence Bouches Du Rhône France Details
AP-HM RECRUITING Marseille Bouches Du Rhône France Details
HIA Sainte Anne RECRUITING Toulon Var France Details
CHU Angers RECRUITING Angers France Details
CHU Bordeaux RECRUITING Bordeaux France Details
CHU Brest RECRUITING Brest France Details
Centre François Baclesse RECRUITING Caen France Details
CH Chambéry RECRUITING Chambéry France Details
Hôpitaux civils de Colmar RECRUITING Colmar France Details
CHI Créteil RECRUITING Créteil France Details
CHD Vendée RECRUITING La Roche-sur-Yon France Details
CHRU Lille RECRUITING Lille France Details
CHU Limoges RECRUITING Limoges France Details
Hospices Civils de Lyon RECRUITING Lyon France Details
CH Cornouaille RECRUITING Quimper France Details
CHU Rennes RECRUITING Rennes France Details
CHU Rouen RECRUITING Rouen France Details
Hôpital Foch RECRUITING Suresnes France Details
CHU Toulouse RECRUITING Toulouse France Details
Hôpitaux Nord-Ouest RECRUITING Villefranche-sur-Saône France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field